Cargando…
The immune system in Duchenne muscular dystrophy: Friend or foe
Duchenne muscular dystrophy (DMD) is a genetic disease caused by mutations in the X-linked dystrophin gene, resulting in reduced or absent protein production, subsequently leading to the structural instability of the dystroglycan complex (DGC), muscle degeneration, and early death in males. Thus, cu...
Autores principales: | Villalta, S Armando, Rosenberg, Amy S, Bluestone, Jeffrey A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588155/ https://www.ncbi.nlm.nih.gov/pubmed/26481612 http://dx.doi.org/10.1080/21675511.2015.1010966 |
Ejemplares similares
-
Simvastatin offers new prospects for the treatment of Duchenne muscular dystrophy
por: Whitehead, Nicholas P., et al.
Publicado: (2016) -
Muscle-specific microRNAs as biomarkers of Duchenne Muscular Dystrophy progression and response to therapies
por: Giordani, L, et al.
Publicado: (2014) -
Drosophila as a starting point for developing therapeutics for the rare disease Duchenne Muscular Dystrophy
por: Pantoja, Mario, et al.
Publicado: (2013) -
Inflammatory bactericidal lectin RegIIIβ: Friend or foe for the host?
por: Miki, Tsuyoshi, et al.
Publicado: (2017) -
Facioscapulohumeral muscular dystrophy: Are telomeres the end of the story?
por: Stadler, Guido, et al.
Publicado: (2013)